Rocket Lab Balances a Record Launch Pipeline Against the Weight of Its Iridium Bet

Rocket Lab's order book passes 100 missions after a 20-launch Synspective deal, while Iridium shareholders back a merger targeted for mid-2027.

Rocket Lab's dual identity — dependable small-launch operator and would-be satellite communications giant — was on full display this week, with fresh contract wins underscoring demand for its Electron rocket even as the financial heft of its pending Iridium Communications acquisition draws closer scrutiny.

The stock changed hands at EUR 62.80 in the prior session, sitting 4.0% above its 50-day moving average of EUR 60.41. A day later, shares added 1.3% to reach EUR 62.40. That remains a long way from the 52-week high of EUR 133.80, a gap that speaks to how cautiously the market is pricing the capital measures tied to the Iridium deal and the lengthy path to closing in 2027.

A Backlog Built on Repeat Business

The clearest evidence of Rocket Lab's operational momentum came from Tokyo-based Synspective, which signed a multi-year agreement for 20 additional Electron launches. It ranks as the company's largest single commercial contract for the light-lift vehicle to date. Flights are scheduled to run annually from 2028 through 2031, lifting Synspective's total bookings to 47 missions. Neither party disclosed the financial terms, but the arrangement gives Rocket Lab a dependable utilization runway for its launch system well into the next decade.

Taken together, Rocket Lab's total order book now exceeds 100 missions. That figure reflects unbroken appetite for reliable transport to low Earth orbit — a niche where Electron has established itself as a workhorse, and one that affords planning certainty few competitors can match.

The launch cadence backing up those bookings has been brisk. On September 19, the 96th Electron mission carried Synspective's twelfth StriX satellite into orbit, delivering the payload precisely to low Earth orbit and advancing the Japanese customer's radar-based Earth-observation constellation. Days later, on September 26, the 97th mission — dubbed "Owlright Owlright Owlright" — placed another StriX radar satellite successfully in space for the same partner.

Iridium Shareholders Give the Deal a Green Light

While the launch business hums along, Rocket Lab is clearing the runway for its biggest strategic move. Roughly a week ago, Iridium Communications shareholders approved the merger agreement, paving the way for Rocket Lab to take over the satellite communications provider outright. The vote was emphatic: about 99.6% of ballots cast backed the combination, representing roughly 81.0% of Iridium's voting shares.

Completion, however, is not imminent. The transaction still hinges on regulatory approvals and other customary closing conditions, with the parties targeting mid-2027 to finalize.

Financing the deal has already left its mark on the share count. In mid-September, Rocket Lab completed an equity placement of 29.3 million new shares, raising approximately USD 1.944 billion in gross proceeds. The move retired a USD 3.6 billion bridge financing facility, but it also dilutes existing shareholders meaningfully — a trade-off the market has been weighing against the strategic rationale.

The Question Mark Over the Expansion

The integration will absorb management attention and billions in capital for months. Should regulatory requirements push back the timeline, or should Iridium's operating performance falter, the hoped-for transformation could quickly turn into a drag.

That tension explains the stock's muted posture. The market is cautiously discounting the risks of the capital measures and the long road to a 2027 close, tempering the enthusiasm generated by the rocket business. Near term, uncertainties surrounding the acquisition carry more weight than the growth narrative.

And Rocket Lab is not standing still on the technical front. The company has published an overview of systems designed to support missions beyond low Earth orbit, developments aimed at future flights that could target the Moon and Mars.

For investors, the calculus is straightforward: the expanding backlog provides a solid foundation, but the stock is unlikely to reclaim its full potential until the Iridium integration is visibly on track.